FDA releases long-awaited plan to review first generic versions of pricey biotech drugs

By Associated Press, Updated: Saturday, February 11, 11:24 PM  –  WASHINGTON — The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition. Read more